Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Aclarion, Inc. - Common Stock
(NQ:
ACON
)
4.500
-0.230 (-4.86%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aclarion, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Aclarion Announces Participation at the NASS 37th Annual Meeting
October 10, 2022
Via
ACCESSWIRE
John Keller M.D. to Join Aclarion as a Key Opinion Leader Surgeon Advisor
October 03, 2022
Via
ACCESSWIRE
Nociscan Selected for Inclusion in Pivotal National Institutes of Health (NIH) Study for Low Back Pain
September 19, 2022
Via
ACCESSWIRE
Why Everbridge Jumped Over 17%; Here Are 90 Biggest Movers From Friday
August 29, 2022
Gainers Micro Focus International plc (NYSE: MFGP) shares surged 92% to close at $6.01 on Friday after the company reached an agreement with OpenText to be acquired for $6 billion.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 26, 2022
Via
Benzinga
Peering Into Aclarion's Recent Short Interest
August 22, 2022
Aclarion's (NASDAQ:ACON) short percent of float has fallen 8.79% since its last report. The company recently reported that it has 112 thousand shares sold short, which is 3.01% of...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
August 18, 2022
Via
Benzinga
Aclarion, Inc. (NASDAQ: ACON) Featured in Coverage of Investor Summit Group’s Q3 Virtual Event
August 12, 2022
Via
Investor Brand Network
Aclarion Announces Start of Healthcare Economic Analysis Study to Evaluate Financial Impact of Nociscan
July 20, 2022
Via
ACCESSWIRE
Why Is Marker Therapeutics Trading Higher By 119%: Here Are 42 Stocks Moving Premarket
August 05, 2022
Gainers Assure Holdings Corp. (NASDAQ: IONM) shares rose 141.4% to $5.07 in pre-market trading after jumping around 104% on Thursday.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 03, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 02, 2022
Gainers Applied DNA Sciences (NASDAQ:APDN) stock rose 90.0% to $5.32 during Tuesday's after-market session. At the close, Applied DNA Sciences's trading volume reached 28.8 million shares. This is...
Via
Benzinga
Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday
August 03, 2022
Gainers MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese stocks.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 02, 2022
Via
Benzinga
Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session
August 02, 2022
Gainers AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.
Via
Benzinga
This Financial Services Is Trading Higher By Over 217%; Here Are 38 Stocks Moving Premarket
August 02, 2022
Gainers AMTD IDEA Group (NYSE: AMTD) rose 217.3% to $6.60 in pre-market trading after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.
Via
Benzinga
Aclarion Announces Start of Healthcare Economic Analysis Study to Evaluate Financial Impact of Nociscan
July 20, 2022
Initial findings from the EVAL study are expected to be released in Q4 2022
From
Aclarion Inc.
Via
AccessWire
Twitter, Delta Air Lines And 45 Stocks Moving In Wednesday's Mid-Day Session
July 13, 2022
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 122.4% to $6.76. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.
Via
Benzinga
Twitter Shares Surge Around 8%, Here's 66 Biggest Movers From Yesterday
July 14, 2022
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares climbed 71.1% to close at $5.20. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
July 13, 2022
Good morning, investors! We're starting off the day with a breakdown of the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
This Healthcare Stock is Down By More Than 50%: Here's 25 Stocks Moving Premarket
July 13, 2022
Gainers
Via
Benzinga
Boeing, PriceSmart And 80 Biggest Movers From Yesterday
July 13, 2022
Gainers Sharps Compliance Corp. (NASDAQ: SMED) shares jumped 196.1% to close at $8.44 on Tuesday after the company it will be acquired by an affiliate of Aurora Capital Partners for $8.75 per share.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2022
July 06, 2022
Upgrades
Via
Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
June 22, 2022
Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares jumped 116.6% to $12.82 after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 22, 2022
Via
Benzinga
Aclarion to Present 2-year Follow Up Data on Pivotal Clinical Trial Linking Nociscan to Better Surgical Outcomes for Discogenic Low Back Pain
June 22, 2022
Superior Clinical Outcomes for NociscanTM Proving to be Durable at Two Years
From
Aclarion Inc.
Via
AccessWire
Stocks That Hit 52-Week Lows On Monday
June 06, 2022
Monday's session saw 84 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
June 03, 2022
During Friday's trading, 69 companies set new 52-week lows.
Via
Benzinga
71 Biggest Movers From Yesterday
May 25, 2022
Gainers CynergisTek, Inc. (NYSE: CTEK) shares surged 100% to close at $1.18 on Tuesday after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7...
Via
Benzinga
71 Biggest Movers From Yesterday
May 20, 2022
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.